IPF, fibrotic hypersensitivity pneumonitis profiles differ
PHOENIX — When examining sphingolipid profiles in patients with idiopathic pulmonary fibrosis and patients with fibrotic hypersensitivity pneumonitis, different signatures emerged, according to data presented at the CHEST Annual Meeting.
“Distinguishing IPF from fibrotic hypersensitivity pneumonitis (fHP) is a challenge in both academic centers and community practice,” Jon Mullholand, MD, assistant professor at Virginia Commonwealth University, told Healio. “A major obstacle is that an inciting antigen often cannot be identified in patients with fHP, and the remaining clinical, imaging and